Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages

M. T.Audrey Nguyen, Ai Chen, Wendell J. Lu, Wu Qiang Fan, Ping Ping Li, Dayoung Oh, David Patsouris

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: PPARγ plays a key role in adipocyte biology, and Rosiglitazone (Rosi), a thiazolidinedione (TZD)/PPARγ agonist, is a potent insulin-sensitizing agent. Recent evidences demonstrate that adipose tissue inflammation links obesity with insulin resistance and that the insulin-sensitizing effects of TZDs result, in part, from their anti-inflammatory properties. However the underlying mechanisms are unclear. Methodology and Principal Findings: In this study, we establish a link between free fatty acids (FFAs) and PPARγ in the context of obesity-associated inflammation. We show that treatment of adipocytes with FFAs, in particular Arachidonic Acid (ARA), downregulates PPARγ protein and mRNA levels. Furthermore, we demonstrate that the downregulation of PPARγ by ARA requires the activation the of Endoplamsic Reticulum (ER) stress by the TLR4 pathway. Knockdown of adipocyte PPARγ resulted in upregulation of MCP1 gene expression and secretion, leading to enhanced macrophage chemotaxis. Rosi inhibited these effects. In a high fat feeding mouse model, we show that Rosi treatment decreases recruitment of proinflammatory macrophages to epididymal fat. This correlates with decreased chemokine and decreased chemokine receptor expression in adipocytes and macrophages, respectively. Conclusions and Significance: In summary, we describe a novel link between FAs, the TLR4/ER stress pathway and PPARγ, and adipocyte-driven recruitment of macrophages. We thus both describe an additional potential mechanism for the anti-inflammatory and insulin-sensitizing actions of TZDs and an additional detrimental property associated with the activation of the TLR4 pathway by FA.

Original languageEnglish (US)
Article numbere34976
JournalPLoS One
Volume7
Issue number4
DOIs
StatePublished - Apr 17 2012

Fingerprint

Peroxisome Proliferator-Activated Receptors
Macrophages
Chemokine Receptors
chemokines
adipocytes
rosiglitazone
Chemokines
Adipocytes
macrophages
insulin
reticulum
Insulin
arachidonic acid
Reticulum
free fatty acids
obesity
inflammation
Nonesterified Fatty Acids
Arachidonic Acid
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Nguyen, M. T. A., Chen, A., Lu, W. J., Fan, W. Q., Li, P. P., Oh, D., & Patsouris, D. (2012). Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages. PLoS One, 7(4), [e34976]. https://doi.org/10.1371/journal.pone.0034976

Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages. / Nguyen, M. T.Audrey; Chen, Ai; Lu, Wendell J.; Fan, Wu Qiang; Li, Ping Ping; Oh, Dayoung; Patsouris, David.

In: PLoS One, Vol. 7, No. 4, e34976, 17.04.2012.

Research output: Contribution to journalArticle

Nguyen, M. T.Audrey ; Chen, Ai ; Lu, Wendell J. ; Fan, Wu Qiang ; Li, Ping Ping ; Oh, Dayoung ; Patsouris, David. / Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages. In: PLoS One. 2012 ; Vol. 7, No. 4.
@article{ad110b4b22524875a072bf6a5e1316f3,
title = "Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages",
abstract = "Background: PPARγ plays a key role in adipocyte biology, and Rosiglitazone (Rosi), a thiazolidinedione (TZD)/PPARγ agonist, is a potent insulin-sensitizing agent. Recent evidences demonstrate that adipose tissue inflammation links obesity with insulin resistance and that the insulin-sensitizing effects of TZDs result, in part, from their anti-inflammatory properties. However the underlying mechanisms are unclear. Methodology and Principal Findings: In this study, we establish a link between free fatty acids (FFAs) and PPARγ in the context of obesity-associated inflammation. We show that treatment of adipocytes with FFAs, in particular Arachidonic Acid (ARA), downregulates PPARγ protein and mRNA levels. Furthermore, we demonstrate that the downregulation of PPARγ by ARA requires the activation the of Endoplamsic Reticulum (ER) stress by the TLR4 pathway. Knockdown of adipocyte PPARγ resulted in upregulation of MCP1 gene expression and secretion, leading to enhanced macrophage chemotaxis. Rosi inhibited these effects. In a high fat feeding mouse model, we show that Rosi treatment decreases recruitment of proinflammatory macrophages to epididymal fat. This correlates with decreased chemokine and decreased chemokine receptor expression in adipocytes and macrophages, respectively. Conclusions and Significance: In summary, we describe a novel link between FAs, the TLR4/ER stress pathway and PPARγ, and adipocyte-driven recruitment of macrophages. We thus both describe an additional potential mechanism for the anti-inflammatory and insulin-sensitizing actions of TZDs and an additional detrimental property associated with the activation of the TLR4 pathway by FA.",
author = "Nguyen, {M. T.Audrey} and Ai Chen and Lu, {Wendell J.} and Fan, {Wu Qiang} and Li, {Ping Ping} and Dayoung Oh and David Patsouris",
year = "2012",
month = "4",
day = "17",
doi = "10.1371/journal.pone.0034976",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages

AU - Nguyen, M. T.Audrey

AU - Chen, Ai

AU - Lu, Wendell J.

AU - Fan, Wu Qiang

AU - Li, Ping Ping

AU - Oh, Dayoung

AU - Patsouris, David

PY - 2012/4/17

Y1 - 2012/4/17

N2 - Background: PPARγ plays a key role in adipocyte biology, and Rosiglitazone (Rosi), a thiazolidinedione (TZD)/PPARγ agonist, is a potent insulin-sensitizing agent. Recent evidences demonstrate that adipose tissue inflammation links obesity with insulin resistance and that the insulin-sensitizing effects of TZDs result, in part, from their anti-inflammatory properties. However the underlying mechanisms are unclear. Methodology and Principal Findings: In this study, we establish a link between free fatty acids (FFAs) and PPARγ in the context of obesity-associated inflammation. We show that treatment of adipocytes with FFAs, in particular Arachidonic Acid (ARA), downregulates PPARγ protein and mRNA levels. Furthermore, we demonstrate that the downregulation of PPARγ by ARA requires the activation the of Endoplamsic Reticulum (ER) stress by the TLR4 pathway. Knockdown of adipocyte PPARγ resulted in upregulation of MCP1 gene expression and secretion, leading to enhanced macrophage chemotaxis. Rosi inhibited these effects. In a high fat feeding mouse model, we show that Rosi treatment decreases recruitment of proinflammatory macrophages to epididymal fat. This correlates with decreased chemokine and decreased chemokine receptor expression in adipocytes and macrophages, respectively. Conclusions and Significance: In summary, we describe a novel link between FAs, the TLR4/ER stress pathway and PPARγ, and adipocyte-driven recruitment of macrophages. We thus both describe an additional potential mechanism for the anti-inflammatory and insulin-sensitizing actions of TZDs and an additional detrimental property associated with the activation of the TLR4 pathway by FA.

AB - Background: PPARγ plays a key role in adipocyte biology, and Rosiglitazone (Rosi), a thiazolidinedione (TZD)/PPARγ agonist, is a potent insulin-sensitizing agent. Recent evidences demonstrate that adipose tissue inflammation links obesity with insulin resistance and that the insulin-sensitizing effects of TZDs result, in part, from their anti-inflammatory properties. However the underlying mechanisms are unclear. Methodology and Principal Findings: In this study, we establish a link between free fatty acids (FFAs) and PPARγ in the context of obesity-associated inflammation. We show that treatment of adipocytes with FFAs, in particular Arachidonic Acid (ARA), downregulates PPARγ protein and mRNA levels. Furthermore, we demonstrate that the downregulation of PPARγ by ARA requires the activation the of Endoplamsic Reticulum (ER) stress by the TLR4 pathway. Knockdown of adipocyte PPARγ resulted in upregulation of MCP1 gene expression and secretion, leading to enhanced macrophage chemotaxis. Rosi inhibited these effects. In a high fat feeding mouse model, we show that Rosi treatment decreases recruitment of proinflammatory macrophages to epididymal fat. This correlates with decreased chemokine and decreased chemokine receptor expression in adipocytes and macrophages, respectively. Conclusions and Significance: In summary, we describe a novel link between FAs, the TLR4/ER stress pathway and PPARγ, and adipocyte-driven recruitment of macrophages. We thus both describe an additional potential mechanism for the anti-inflammatory and insulin-sensitizing actions of TZDs and an additional detrimental property associated with the activation of the TLR4 pathway by FA.

UR - http://www.scopus.com/inward/record.url?scp=84859822353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859822353&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0034976

DO - 10.1371/journal.pone.0034976

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e34976

ER -